Why the study?
Does percutaneous implantation of an entirely intracardiac leadless pacemaker meet pacing and sensing requirements in patients?
Design
Cohort
Authors
Loading...
Supports feasibility in selected patients despite ~6.6% serious adverse events; leaves open long-term safety and comparative efficacy.
Does percutaneous implantation of an entirely intracardiac leadless pacemaker meet pacing and sensing requirements in patients?
An entirely intracardiac leadless pacemaker successfully met pacing and sensing requirements, though device-related serious adverse events occurred in roughly 6.6% of patients.
Reddy et al. (2015) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: